Immunocompomised children are children with a disorder that affects their immune system. This makes them vulnerable to all different kinds of diseases which can be dangerous to their health. The problem with the disease is the fact that it stops the children from getting the vaccination they need. This causes a lot of negative side effects in their lifecycle and is very dangerous together with their existing disorder.
However, a recent study conducted by a team of researchers were able to find a new discovery to help children with immunocompromised disorders to be able to take the vaccination without negative effects. The study will be presented in the conference known as the Pediatric Academic Societies (PAS) 2019 Meeting, taking place on April 24 – May 1 in Baltimore.
The study was led by Dr. Vidya Sivaraman. He commented on his study and results saying, “Immunosuppressive medications have dramatically improved the outcomes of autoimmune diseases such as lupus and inflammatory bowel disease (IBD. While the long-term outcomes of these patients have improved, their care has become more complex and fragmented between the specialist and primary care physician (PCP). We realized that vaccination in these patients has been suboptimal, leaving these patients susceptible to many vaccine-preventable diseases. In this study, our primary aim was to assess vaccine knowledge, comfort, and vaccination practices among parents and PCPs of children with childhood onset systemic lupus and IBD and determine measures to reduce these gaps in preventive care.”